Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenue, net $ 32,398 $ 24,220
Cost of revenue (excluding amortization of $4,461 and $3,989, respectively) 21,673 15,888
Gross profit 10,725 8,332
Operating expenses:    
Sales and marketing 9,254 11,116
Research and development 2,795 2,810
General and administrative 20,770 14,363
Acquisition related expense 2,534
Acquisition related amortization expense 4,461 3,989
Change in fair value of contingent consideration (489) (44)
Total operating expenses 36,791 34,768
Operating loss (26,066) (26,436)
Interest accretion expense (549) (440)
Other income (expense), net 467 196
Loss from continuing operations before tax (26,148) (26,680)
Provision (benefit) for income taxes 53 (28)
Loss from continuing operations (26,201) (26,652)
Loss from discontinued operations, net of tax (250) (88)
Net loss (26,451) (26,740)
Less dividends on preferred stock (429)
Less adjustment for preferred stock deemed dividend (3,033)
Net loss attributable to common stockholders $ (29,484) $ (27,169)
Basic and diluted (loss) income per share of common stock:    
From continuing operations $ (7.26) $ (7.23)
From discontinued operations (0.06) (0.02)
Net loss per basic and diluted share of common stock $ (7.32) $ (7.25)
Weighted average number of common shares and common share equivalents outstanding:    
Basic 4,029,000 3,746,000
Diluted 4,029,000 3,746,000